Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP624094.RA-L3ohNHYqAIjMpL-fgsmpzBJD7cD6oLO6UTs7GZRJR4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP624094.RA-L3ohNHYqAIjMpL-fgsmpzBJD7cD6oLO6UTs7GZRJR4130_assertion type Assertion NP624094.RA-L3ohNHYqAIjMpL-fgsmpzBJD7cD6oLO6UTs7GZRJR4130_head.
- NP624094.RA-L3ohNHYqAIjMpL-fgsmpzBJD7cD6oLO6UTs7GZRJR4130_assertion description "[In addition, important genes, molecular abnormalities, and significant pathways of pancreatic cancer are analyzed and a potential clinical interpretation is presented (p16/cdkn2a, k-ras mutations, smad-4/tgf-/stat3, stk-11, braf, brca-2, neurotensin, mucs proteins, palb2, mitochondrial mutations, DNA mismatch repair genes, methylation, microrna expression, epithelial-to-mesenchymal transition, egfr mutations, the pi3k-akt-mtor pathway, the vegf pathway, heat shock proteins, cxcr4, the cox pathway, the src pathway, the hedgehog pathway, pancreatic stellate cells, a progression model, and molecular events in uncommon pancreatic tumors).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624094.RA-L3ohNHYqAIjMpL-fgsmpzBJD7cD6oLO6UTs7GZRJR4130_provenance.
- NP624094.RA-L3ohNHYqAIjMpL-fgsmpzBJD7cD6oLO6UTs7GZRJR4130_assertion evidence source_evidence_literature NP624094.RA-L3ohNHYqAIjMpL-fgsmpzBJD7cD6oLO6UTs7GZRJR4130_provenance.
- NP624094.RA-L3ohNHYqAIjMpL-fgsmpzBJD7cD6oLO6UTs7GZRJR4130_assertion SIO_000772 22116519 NP624094.RA-L3ohNHYqAIjMpL-fgsmpzBJD7cD6oLO6UTs7GZRJR4130_provenance.
- NP624094.RA-L3ohNHYqAIjMpL-fgsmpzBJD7cD6oLO6UTs7GZRJR4130_assertion wasDerivedFrom befree-20150227 NP624094.RA-L3ohNHYqAIjMpL-fgsmpzBJD7cD6oLO6UTs7GZRJR4130_provenance.
- NP624094.RA-L3ohNHYqAIjMpL-fgsmpzBJD7cD6oLO6UTs7GZRJR4130_assertion wasGeneratedBy ECO_0000203 NP624094.RA-L3ohNHYqAIjMpL-fgsmpzBJD7cD6oLO6UTs7GZRJR4130_provenance.